The role of endothelin receptor antagonists in cardiovascular pharmacotherapy

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.6, Iss.1, 2001-04, pp. : 3-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelin Receptor Antagonists and Cardiovascular Diseases of Aging

By Love M.P.

Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. : 425-439

Adis International

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Mixed results with endothelin receptor antagonists in cardiovascular disorders

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Endothelin Receptor Antagonists - An Overview

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 549-575

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1537-1552

Informa Healthcare

Access to resources Recommend Favorite